- Home
- TSHA vs IRBT Comparison
TSHA vs IRBT Comparison
Compare TSHA & IRBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- IRBT
- Stock Information
- Founded
- TSHA 2019
- IRBT 1990
- Country
- TSHA United States
- IRBT United States
- Employees
- TSHA N/A
- IRBT N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- IRBT Consumer Electronics/Appliances
- Sector
- TSHA Health Care
- IRBT Consumer Discretionary
- Exchange
- TSHA Nasdaq
- IRBT Nasdaq
- Market Cap
- TSHA 262.4M
- IRBT 257.3M
- IPO Year
- TSHA 2020
- IRBT N/A
- Fundamental
- Price
- TSHA $1.24
- IRBT $2.01
- Analyst Decision
- TSHA Strong Buy
- IRBT Hold
- Analyst Count
- TSHA 8
- IRBT 1
- Target Price
- TSHA $6.63
- IRBT N/A
- AVG Volume (30 Days)
- TSHA 2.4M
- IRBT 1.7M
- Earning Date
- TSHA 05-13-2025
- IRBT 05-06-2025
- Dividend Yield
- TSHA N/A
- IRBT N/A
- EPS Growth
- TSHA N/A
- IRBT N/A
- EPS
- TSHA N/A
- IRBT N/A
- Revenue
- TSHA $8,333,000.00
- IRBT $681,849,000.00
- Revenue This Year
- TSHA N/A
- IRBT $7.98
- Revenue Next Year
- TSHA N/A
- IRBT $23.24
- P/E Ratio
- TSHA N/A
- IRBT N/A
- Revenue Growth
- TSHA N/A
- IRBT N/A
- 52 Week Low
- TSHA $1.05
- IRBT $1.76
- 52 Week High
- TSHA $4.32
- IRBT $14.51
- Technical
- Relative Strength Index (RSI)
- TSHA 40.35
- IRBT 28.81
- Support Level
- TSHA $1.05
- IRBT $1.76
- Resistance Level
- TSHA $1.36
- IRBT $2.10
- Average True Range (ATR)
- TSHA 0.17
- IRBT 0.27
- MACD
- TSHA -0.01
- IRBT 0.14
- Stochastic Oscillator
- TSHA 25.68
- IRBT 23.36
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About IRBT iRobot Corporation
iRobot Corp is a united state based consumer robot company. It designs and builds robots that assist consumers with the solutions for the activities to be carried both inside and outside of the home. The company's consumer robot comprises a portfolio of solutions which includes cleaning, mapping and navigation, human-robot interaction, and physical solutions. The company operates in the business segment of Consumer robots. The consumer robot products are provided to the consumers by retail businesses and online store. The company derives its revenue from the product sales. It sells the products across the United States and around the world.